Paul Hamilton Chapman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiosurgery | 23 | 2021 | 1330 | 1.370 |
Why?
|
| Intracranial Arteriovenous Malformations | 12 | 2019 | 360 | 1.340 |
Why?
|
| Meningioma | 3 | 2020 | 1219 | 0.260 |
Why?
|
| Lipoma | 4 | 1995 | 294 | 0.250 |
Why?
|
| Protons | 6 | 2010 | 1101 | 0.250 |
Why?
|
| Brain Diseases | 3 | 2007 | 1551 | 0.230 |
Why?
|
| Neuroma, Acoustic | 3 | 2021 | 455 | 0.230 |
Why?
|
| Brain Neoplasms | 9 | 2018 | 9108 | 0.220 |
Why?
|
| Central Nervous System Vascular Malformations | 3 | 2017 | 141 | 0.210 |
Why?
|
| Neurilemmoma | 2 | 2003 | 522 | 0.210 |
Why?
|
| Hearing Disorders | 1 | 2003 | 126 | 0.210 |
Why?
|
| Hyperemia | 1 | 2004 | 223 | 0.210 |
Why?
|
| Venous Insufficiency | 1 | 2004 | 109 | 0.210 |
Why?
|
| Paresis | 1 | 2003 | 177 | 0.200 |
Why?
|
| Meningocele | 2 | 2000 | 50 | 0.190 |
Why?
|
| Libraries | 1 | 2001 | 21 | 0.190 |
Why?
|
| Aphasia | 1 | 2003 | 193 | 0.190 |
Why?
|
| Ataxia | 1 | 2003 | 307 | 0.180 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2003 | 542 | 0.160 |
Why?
|
| Spinal Cord Neoplasms | 3 | 1994 | 263 | 0.160 |
Why?
|
| Cyclotrons | 1 | 1998 | 30 | 0.150 |
Why?
|
| Cerebral Hemorrhage | 5 | 2019 | 2655 | 0.140 |
Why?
|
| Postoperative Complications | 11 | 2017 | 15824 | 0.140 |
Why?
|
| Cerebrospinal Fluid Shunts | 4 | 1990 | 197 | 0.140 |
Why?
|
| Hydrocephalus | 5 | 2017 | 766 | 0.140 |
Why?
|
| Intracranial Pressure | 4 | 1990 | 323 | 0.140 |
Why?
|
| Ventriculoperitoneal Shunt | 2 | 2017 | 186 | 0.130 |
Why?
|
| Radiotherapy | 1 | 2003 | 1500 | 0.130 |
Why?
|
| Pineal Gland | 2 | 1992 | 158 | 0.130 |
Why?
|
| Watchful Waiting | 1 | 2020 | 492 | 0.130 |
Why?
|
| Vision Disorders | 1 | 2003 | 1090 | 0.130 |
Why?
|
| Neurofibromatosis 1 | 2 | 2000 | 561 | 0.130 |
Why?
|
| Behavior, Animal | 1 | 2003 | 1865 | 0.130 |
Why?
|
| Meningomyelocele | 2 | 1995 | 182 | 0.120 |
Why?
|
| Telemetry | 3 | 1994 | 201 | 0.120 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2020 | 1788 | 0.120 |
Why?
|
| Syringomyelia | 1 | 1995 | 66 | 0.120 |
Why?
|
| Patient Positioning | 1 | 2017 | 332 | 0.120 |
Why?
|
| Hippocampus | 2 | 2004 | 3777 | 0.110 |
Why?
|
| Embolization, Therapeutic | 3 | 2017 | 1403 | 0.110 |
Why?
|
| Pinealoma | 2 | 1992 | 52 | 0.110 |
Why?
|
| Cranial Irradiation | 1 | 2016 | 393 | 0.110 |
Why?
|
| Brain Stem | 4 | 2011 | 858 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2007 | 36582 | 0.100 |
Why?
|
| Dose-Response Relationship, Radiation | 3 | 2006 | 876 | 0.100 |
Why?
|
| Embalming | 1 | 2011 | 13 | 0.100 |
Why?
|
| Mummies | 1 | 2011 | 10 | 0.100 |
Why?
|
| Radiation Injuries | 4 | 2018 | 1196 | 0.090 |
Why?
|
| Radiotherapy Dosage | 6 | 2016 | 2915 | 0.090 |
Why?
|
| Spinal Neoplasms | 2 | 1995 | 714 | 0.090 |
Why?
|
| Facial Bones | 1 | 2011 | 209 | 0.090 |
Why?
|
| Cavernous Sinus | 2 | 2001 | 121 | 0.080 |
Why?
|
| Intracranial Aneurysm | 1 | 2019 | 1271 | 0.080 |
Why?
|
| Acromegaly | 2 | 2014 | 315 | 0.080 |
Why?
|
| Myelography | 4 | 1995 | 72 | 0.080 |
Why?
|
| Child | 24 | 2019 | 80771 | 0.080 |
Why?
|
| Encephalocele | 1 | 1989 | 135 | 0.080 |
Why?
|
| Organs at Risk | 1 | 2010 | 367 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2003 | 3461 | 0.070 |
Why?
|
| Nelson Syndrome | 1 | 2007 | 20 | 0.070 |
Why?
|
| Occipital Lobe | 1 | 1989 | 376 | 0.070 |
Why?
|
| Pituitary Neoplasms | 2 | 2014 | 1322 | 0.070 |
Why?
|
| Neurosurgical Procedures | 2 | 2017 | 2075 | 0.070 |
Why?
|
| Cerebral Angiography | 3 | 2017 | 1263 | 0.070 |
Why?
|
| Adolescent | 21 | 2014 | 89046 | 0.070 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2016 | 1677 | 0.070 |
Why?
|
| History, Ancient | 2 | 2011 | 213 | 0.070 |
Why?
|
| Necrosis | 2 | 2018 | 1614 | 0.070 |
Why?
|
| Osteotomy | 1 | 2011 | 837 | 0.060 |
Why?
|
| Adenoma | 2 | 2014 | 2155 | 0.060 |
Why?
|
| Follow-Up Studies | 11 | 2021 | 39317 | 0.060 |
Why?
|
| Male | 41 | 2020 | 364203 | 0.060 |
Why?
|
| Posture | 1 | 1990 | 956 | 0.060 |
Why?
|
| Retrospective Studies | 14 | 2021 | 81659 | 0.060 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2007 | 180 | 0.060 |
Why?
|
| Treatment Outcome | 13 | 2021 | 65295 | 0.060 |
Why?
|
| Humans | 55 | 2021 | 767040 | 0.060 |
Why?
|
| Adult | 30 | 2018 | 223317 | 0.060 |
Why?
|
| Epilepsy | 2 | 2002 | 3317 | 0.060 |
Why?
|
| Meningeal Neoplasms | 2 | 2010 | 1253 | 0.060 |
Why?
|
| Spinal Canal | 1 | 1984 | 42 | 0.060 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 1984 | 43 | 0.060 |
Why?
|
| Middle Aged | 26 | 2020 | 223233 | 0.060 |
Why?
|
| Glasgow Outcome Scale | 2 | 2003 | 101 | 0.060 |
Why?
|
| Female | 38 | 2020 | 396660 | 0.060 |
Why?
|
| Craniotomy | 2 | 2003 | 736 | 0.060 |
Why?
|
| Particle Accelerators | 2 | 2006 | 172 | 0.050 |
Why?
|
| Cysts | 2 | 1990 | 685 | 0.050 |
Why?
|
| Cranial Nerves | 1 | 2003 | 97 | 0.050 |
Why?
|
| Cerebral Veins | 1 | 2004 | 157 | 0.050 |
Why?
|
| Brain | 3 | 2018 | 27163 | 0.050 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2003 | 369 | 0.050 |
Why?
|
| Abducens Nerve | 1 | 1981 | 28 | 0.050 |
Why?
|
| Greek World | 1 | 2001 | 6 | 0.050 |
Why?
|
| Benzoxazines | 1 | 2003 | 320 | 0.050 |
Why?
|
| Oxazines | 1 | 2003 | 358 | 0.050 |
Why?
|
| Coloring Agents | 1 | 2003 | 565 | 0.050 |
Why?
|
| Epoxide Hydrolases | 1 | 1981 | 122 | 0.050 |
Why?
|
| Relative Biological Effectiveness | 2 | 2014 | 313 | 0.050 |
Why?
|
| Brain Stem Neoplasms | 1 | 2003 | 191 | 0.040 |
Why?
|
| Mesencephalon | 1 | 2003 | 338 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2003 | 1263 | 0.040 |
Why?
|
| Seizures | 3 | 2014 | 2996 | 0.040 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 1981 | 101 | 0.040 |
Why?
|
| Lipomatosis | 1 | 1981 | 112 | 0.040 |
Why?
|
| Neurosurgery | 1 | 2007 | 682 | 0.040 |
Why?
|
| Child, Preschool | 9 | 2014 | 42606 | 0.040 |
Why?
|
| Paralysis | 1 | 1981 | 250 | 0.040 |
Why?
|
| Aged | 18 | 2020 | 171319 | 0.040 |
Why?
|
| Benzopyrene Hydroxylase | 1 | 1979 | 1 | 0.040 |
Why?
|
| Cushing Syndrome | 1 | 1981 | 241 | 0.040 |
Why?
|
| Brain Mapping | 1 | 1995 | 6597 | 0.040 |
Why?
|
| Spinal Cord Compression | 1 | 1981 | 234 | 0.040 |
Why?
|
| Science | 1 | 2001 | 234 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 1995 | 5754 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 1999 | 318 | 0.040 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 1979 | 246 | 0.040 |
Why?
|
| Biophysics | 1 | 1999 | 376 | 0.040 |
Why?
|
| Skull Base | 1 | 2000 | 294 | 0.040 |
Why?
|
| Spinal Cord | 2 | 1993 | 1811 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 12069 | 0.040 |
Why?
|
| Transverse Sinuses | 1 | 2017 | 25 | 0.040 |
Why?
|
| Biotechnology | 1 | 1999 | 282 | 0.030 |
Why?
|
| Thalamus | 1 | 2003 | 1040 | 0.030 |
Why?
|
| Skin | 2 | 1981 | 4499 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2019 | 20741 | 0.030 |
Why?
|
| Visual Fields | 1 | 2003 | 1063 | 0.030 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2017 | 331 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2004 | 8108 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2020 | 1824 | 0.030 |
Why?
|
| Nervous System | 1 | 1998 | 543 | 0.030 |
Why?
|
| S100 Proteins | 2 | 1994 | 216 | 0.030 |
Why?
|
| Hemangioblastoma | 1 | 1994 | 62 | 0.030 |
Why?
|
| Aneurysm, Ruptured | 1 | 2019 | 455 | 0.030 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 1994 | 38 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2014 | 6215 | 0.030 |
Why?
|
| Memory | 1 | 2003 | 2192 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 1999 | 903 | 0.030 |
Why?
|
| Infant | 6 | 2003 | 36485 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 6513 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2003 | 2978 | 0.030 |
Why?
|
| Hematoma, Subdural | 1 | 1994 | 128 | 0.030 |
Why?
|
| Infant, Newborn | 4 | 2003 | 26396 | 0.030 |
Why?
|
| Aged, 80 and over | 6 | 2018 | 59548 | 0.030 |
Why?
|
| Cauda Equina | 2 | 1984 | 45 | 0.030 |
Why?
|
| Hypopituitarism | 1 | 2014 | 253 | 0.020 |
Why?
|
| Empyema, Subdural | 1 | 1992 | 12 | 0.020 |
Why?
|
| Subdural Effusion | 1 | 1992 | 19 | 0.020 |
Why?
|
| Reticulin | 1 | 1992 | 19 | 0.020 |
Why?
|
| Time Factors | 4 | 2018 | 40154 | 0.020 |
Why?
|
| Spinal Cord Diseases | 1 | 1994 | 291 | 0.020 |
Why?
|
| Skull Neoplasms | 1 | 1992 | 173 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2018 | 2658 | 0.020 |
Why?
|
| Young Adult | 5 | 2018 | 59980 | 0.020 |
Why?
|
| Headache Disorders, Secondary | 1 | 2011 | 34 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2018 | 1271 | 0.020 |
Why?
|
| Recurrence | 2 | 2001 | 8504 | 0.020 |
Why?
|
| Nerve Compression Syndromes | 2 | 1984 | 160 | 0.020 |
Why?
|
| Radiotherapy, Conformal | 1 | 2014 | 548 | 0.020 |
Why?
|
| Vimentin | 1 | 1992 | 257 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 2011 | 365 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2014 | 834 | 0.020 |
Why?
|
| Rats | 2 | 2004 | 23713 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 1999 | 1965 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 1993 | 913 | 0.020 |
Why?
|
| Chondrosarcoma | 1 | 1992 | 305 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 11063 | 0.020 |
Why?
|
| Meningitis, Bacterial | 1 | 1992 | 222 | 0.020 |
Why?
|
| Angiomatosis | 1 | 1989 | 46 | 0.020 |
Why?
|
| Eosinophilia | 1 | 1994 | 554 | 0.020 |
Why?
|
| Radiography | 2 | 2014 | 6975 | 0.020 |
Why?
|
| Basal Ganglia | 1 | 2011 | 549 | 0.020 |
Why?
|
| Logistic Models | 1 | 2003 | 13284 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1992 | 2551 | 0.020 |
Why?
|
| Skull Fractures | 1 | 1990 | 202 | 0.020 |
Why?
|
| Meninges | 1 | 1990 | 197 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 1547 | 0.020 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1992 | 390 | 0.020 |
Why?
|
| Bromocriptine | 1 | 2007 | 93 | 0.020 |
Why?
|
| Growth Hormone-Secreting Pituitary Adenoma | 1 | 2007 | 49 | 0.020 |
Why?
|
| Cerebellar Diseases | 1 | 1989 | 227 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 12536 | 0.020 |
Why?
|
| Cerebral Ventricles | 1 | 1989 | 550 | 0.020 |
Why?
|
| Cadaver | 1 | 2011 | 1362 | 0.020 |
Why?
|
| Hamartoma | 1 | 1989 | 235 | 0.020 |
Why?
|
| Octreotide | 1 | 2007 | 156 | 0.020 |
Why?
|
| Photons | 1 | 2010 | 592 | 0.020 |
Why?
|
| Intracranial Hemorrhages | 1 | 2011 | 810 | 0.020 |
Why?
|
| Helium | 1 | 2006 | 119 | 0.020 |
Why?
|
| History, 20th Century | 1 | 1994 | 2765 | 0.020 |
Why?
|
| Equipment Design | 1 | 1994 | 3489 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2010 | 1012 | 0.020 |
Why?
|
| Growth Hormone | 1 | 2007 | 572 | 0.020 |
Why?
|
| Prognosis | 2 | 2003 | 29963 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2010 | 1903 | 0.010 |
Why?
|
| Gadolinium | 2 | 2004 | 964 | 0.010 |
Why?
|
| Subarachnoid Space | 1 | 1984 | 78 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1992 | 1717 | 0.010 |
Why?
|
| Survival Rate | 1 | 2018 | 12823 | 0.010 |
Why?
|
| Cranial Fossa, Posterior | 1 | 1984 | 134 | 0.010 |
Why?
|
| Endovascular Procedures | 1 | 2017 | 2215 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1994 | 3464 | 0.010 |
Why?
|
| Lumbosacral Region | 1 | 1984 | 294 | 0.010 |
Why?
|
| Cerebellum | 1 | 1989 | 1521 | 0.010 |
Why?
|
| Remission Induction | 1 | 2007 | 2408 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2003 | 24299 | 0.010 |
Why?
|
| Microsomes | 1 | 1981 | 252 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 1993 | 3324 | 0.010 |
Why?
|
| Sarcoma | 1 | 1992 | 1802 | 0.010 |
Why?
|
| Cranial Nerve Diseases | 1 | 1981 | 111 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14672 | 0.010 |
Why?
|
| Patient Satisfaction | 2 | 2003 | 3488 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 2003 | 551 | 0.010 |
Why?
|
| Epidural Space | 1 | 1981 | 123 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2011 | 5311 | 0.010 |
Why?
|
| Quality of Life | 1 | 2021 | 13485 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2007 | 1939 | 0.010 |
Why?
|
| Incidence | 1 | 1998 | 21526 | 0.010 |
Why?
|
| Benz(a)Anthracenes | 1 | 1979 | 11 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2007 | 1840 | 0.010 |
Why?
|
| Risk | 1 | 2011 | 9606 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41718 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 7469 | 0.010 |
Why?
|
| Epidermis | 1 | 1981 | 539 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2010 | 9410 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 20169 | 0.010 |
Why?
|
| Combined Modality Therapy | 2 | 2002 | 8535 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1984 | 1794 | 0.010 |
Why?
|
| Astrocytoma | 1 | 1980 | 773 | 0.010 |
Why?
|
| Heart Atria | 1 | 1981 | 1362 | 0.010 |
Why?
|
| Animals | 2 | 2004 | 168965 | 0.010 |
Why?
|
| Paraplegia | 1 | 1994 | 161 | 0.010 |
Why?
|
| Thoracic Vertebrae | 1 | 1977 | 613 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1994 | 1697 | 0.010 |
Why?
|
| Eosinophils | 1 | 1994 | 951 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1989 | 697 | 0.000 |
Why?
|
| Glioma | 1 | 1980 | 3502 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 18330 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1989 | 1076 | 0.000 |
Why?
|
| Risk Factors | 2 | 2002 | 74886 | 0.000 |
Why?
|
| Age Factors | 1 | 1979 | 18401 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1994 | 9362 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1994 | 12986 | 0.000 |
Why?
|
| Catheterization | 1 | 1979 | 1430 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1992 | 13650 | 0.000 |
Why?
|